India-US tariff framework

India-US tariff framework: What changes for exporters and imports

Energy, tech and non-tariff barriers shape the India-US tariff framework more than headlines, and the fine print will decide outcomes. #India #US #trade Read more »
menstrual health and the right to life

Menstrual health is enforceable right after Supreme Court ruling

The Supreme Court has held that menstrual health is part of the right to life, issuing binding directions to all schools and reshaping how equality and education are enforced. Read more »
Bangladesh elections

Bangladesh’s exclusionary election and its tryst with democratic renewal

As Bangladesh prepares for elections, the exclusion of the Awami League and concerns over the interim government’s neutrality raise doubts about the legitimacy of the process. Read more »
India-US trade

India-US trade framework: The coercion behind concessions

India-US trade framework cuts tariffs, but links relief to oil choices, purchases and monitoring — raising costs and sovereignty risks. #India #US #trade Read more »
CSR spending on environment

From CSR to constitutional duty to pay the cost of environmental neglect

The Supreme Court has ruled that CSR spending in environmental responsibility is not corporate charity but a constitutional duty. Read more »
India must regulate promoter power

India must regulate promoter power, not just retail volatility

As household capital floods markets, India must regulate promoter power and step up investor protection. Read more »
The India-EU trade agreement

India-EU trade is set to grow; its environmental costs may grow faster

The India-EU trade agreement is expected to expand exports and employment, but there are doubts on whether environmental oversight can keep pace. Read more »
probiotics in modern medicine

Probiotics for cancer and diabetes?

The microbes living in our gut can shape whether certain cutting-edge immunotherapies succeed or fail, turning probiotics into players in modern medicine. Read more »
Medical device manufacturing

Medical device manufacturing runs into structural limits

India’s medical device manufacturing strategy is colliding with gaps in regulation, testing, and high-risk manufacturing, and PLI cannot bridge these alone. #PLI #medicaldevices Read more »
RoDTEP scheme allocation cut by 45%

RoDTEP scheme after Budget 2026: Fiscal tightening, strategic risks

Budget 2026 has cut RoDTEP scheme allocation by 45% to ₹10,000 crore, signalling a shift in India’s export support strategy. Read more »